Upcoming Health Events in Boston, United States

Novel conjugates have become one of the most competitive and rapidly evolving areas in the precision oncology landscape. Companies are looking b...

Cutting-edge AI/ML-driven breakthroughs, including Monte Rosa Therapeutics’ progress in molecular glue degraders, Insilico Medicine’...

Pharma Forum: The Premier Conference for Life Sciences Meeting Professionals

Pharma Forum is the ultimate gat...

The era of blanket immunosuppression is ending. A new chapter in autoimmune therapy is unfolding, one where precision replaces broad suppression...

Cutting-edge breakthroughs in DNA production, from high-yield plasmid manufacturing to next-generation cell-free platforms, are transforming how...

Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams wh...

Welcome to the 3rd GLP-1 Based Therapeutics Summit - the essential industry forum dedicated to solving the critical challenges of GLP-1 combinat...

The Measuring Impact in Medical A_f_f_a_i_r_s Summit is uniting Medical A_f_f_a_i_r_s leaders from across pharma and biotech to define, benchmar...

From transformative genetic therapies in rare diseases to neuroimmunology candidates addressing residual unmet needs in MS, and novel target val...

Regulatory and governmental momentum is forcing change, fast:

The Senate have recently cleared the FDA Modernization Act ...

Optimizing ADC Physiochemical, Potency, and Impurity Analytical Methods to Enhance Product Understanding, Quality and Assess DARs for Regulatory...

Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, w...